1613055-98-3

Basic information

• Product Name: C₃₂H₃₆F₃N₃O₅S
• Synonyms: C₃₂H₃₆F₃N₃O₅S
• CAS NO: 1613055-98-3
• Molecular Weight: 631.716
• Mol File: 1613055-98-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: C₃₂H₃₆F₃N₃O₅S(CAS DataBase Reference)
• NIST Chemistry Reference: C₃₂H₃₆F₃N₃O₅S(1613055-98-3)
• EPA Substance Registry System: C₃₂H₃₆F₃N₃O₅S(1613055-98-3)

Safety Data

• Hazardous Substances Data: 1613055-98-3(Hazardous Substances Data)

Upstream product

• 1612236-52-8 C₁₂H₁₂O₂ 
• 1612236-51-7 C₁₂H₁₀Cl₂O₂ 
• 40243-64-9 4-methoxy-1(H)-indene 
• 67199-57-9 4-methoxy-2,3-dihydro-1H-inden-1-ol 
• 13336-31-7 4-methoxylindanone 
• 40731-98-4 4-hydroxy-2,3-dihydroindan-1-one 
• 119-84-6 C₆H₄(CH₂CH₂C(O)O) 
• 1613055-96-1 C₂₀H₂₆BrN₃O₂ 
• 1613055-95-0 C₂₀H₂₆BrNO₅ 
• 1001353-87-2 (2S)-1-(tert-butoxycarbonyl)-4,4-dimethylpyrrolidine-2-carboxylic acid 
• 138423-86-6 Methyl (2S)-1-(tert-bytoxycarbonyl)-4,4-dimethylprolinate 
• 1612236-56-2 C₁₂H₁₀F₃IO₃S 
• 1613055-97-2 C₂₆H₃₈BN₃O₄ 
• 1612236-55-1 C₁₁H₁₁IO 

Downstream Products

• 1613056-01-1 C₄₉H₆₀N₆O₄ 

Relevant articles and documents

FUSED RING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF

Provided are fused tricyclic compounds effective to inhibit the function of the NS5A protein of formula (I), wherein X, X', Y, Y', A, A',Q1, Q2, R1-R4, X4, R5a, f and W are defined as in the description. Also provided herein are pharmaceutical compositions thereof, and uses in the manufacture of a medicament for treating HCV infection or a HCV disorder thereof.